Pivotal Bio Venture Partners Investment Advisor LLC Inozyme Pharma, Inc. Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $106 Million
- Q2 2025
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 4,494,851 shares of INZY stock, worth $18 Million. This represents 16.98% of its overall portfolio holdings.
Number of Shares
4,494,851
Previous 4,494,851
-0.0%
Holding current value
$18 Million
Previous $4.09 Million
339.58%
% of portfolio
16.98%
Previous 5.72%
Shares
5 transactions
Others Institutions Holding INZY
# of Institutions
88Shares Held
51.9MCall Options Held
162KPut Options Held
0-
Beryl Capital Management LLC Redondo Beach, CA6.32MShares$25.3 Million3.83% of portfolio
-
Glazer Capital, LLC New York, NY4.33MShares$17.3 Million0.62% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$17.1 Million1.16% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$13.4 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I03.2MShares$12.8 Million0.5% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $161M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...